spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Jackson ImmunoResearch Announces New Range of Antibodies for Serology and Diagnostics Market

Jackson Immunoresearch



West Grove, PA – 02 August 2022:
Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets. JIR Mouse Monoclonal Anti-Human IgE antibodies are the latest addition to our suite of products suitable for diagnostics research and development. Specific for Human IgE antibodies, they complement our existing Anti-Human IgG, IgM, and IgA antibodies. Anti-Human IgE is available conjugated to a select range of reporter molecules, including Alkaline Phosphatase and Biotin enabling excellent sensitivity for immunoassay applications. Jackson ImmunoResearch Anti-Human IgE is a mouse-derived monoclonal antibody with reactivity to human E class immunoglobulins and is epsilon (ε) chain specific and has been tested by ELISA and shows minimal cross-reactivity to other classes of human immunoglobulin (IgG, IgM, or IgA).

JIR Mouse Anti-Human IgE is available conjugated to a range of reporter molecules and is suitable to detect human IgE by a variety of techniques, including ELISA (Enzyme-linked Immunosorbent Assay), Lateral Flow Immunoassay (LFIA), Flow cytometry, Western blot, and CLIA (Chemiluminescent Immunoassay).

Matthew Smith, Commercial Director, commented, “We are excited to launch Jackson ImmunoResearch Anti-Human IgE antibodies as part of our existing suite of reagents suitable for developing high-quality human serology and diagnostic tests. They will allow scientists to harness the sensitivity and specificity of JIR antibodies in a wider range of fields such as allergy.”

These antibodies are available for purchase now, directly from Jackson ImmunoResearch in the USA and Europe or through official distribution partners worldwide. More information on JIR Mouse Monoclonal Anti-Human IgE antibodies is available at www.jacksonimmuno.com/ige.
phone (800) 367-5296
email cuserv@jacksonimmuno.com
web www.jacksonimmuno.com/
email ackson ImmunoResearch Laboratories, Inc 872 West Baltimore Pike West Grove, Pennsylvania 19390
 
Print this page
Send to a friend
   
spacer
News and Press Releases

PhoreMost Enters Multi-Project Drug Target Discovery Collaboration With Roche

Cambridge, UK, 06 September 2022: PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has entered into a multi-project target discovery collaboration with Roche, one of the world's leading biotechnology companies. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones. Further financial terms are not disclosed.
More info >>


White Papers

Speciality Logistics Outlook 2015

World Courier

To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement